"Hims & Hers Health Stock Was in Dire Need of This Eli Lilly Agreement"
The commentary argues that Hims & Hers Health's agreement with Eli Lilly was essential for the company's stock performance. It suggests the partnership provides critical validation and growth potential, addressing prior market concerns about the firm's competitive position in the weight-loss drug sector.